Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms RC-0j |
Target |
Action degraders |
Mechanism BTK degraders(Tyrosine-protein kinase BTK degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC58H65N13O14 |
InChIKeyVJMJOGCKUHVNKH-WLHAHUJPSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Preclinical | Israel | 05 May 2020 |